Comments
Commented by Armin Schulz on October 9th, 2025 | 07:40 CEST
AI paves the way to the next blockbuster: The current situation at Novo Nordisk, NetraMark Holdings and Evotec
The pharmaceutical industry is at a historic turning point. Artificial intelligence is breaking through the lengthy and costly development cycles that have characterized the sector for decades. This technological quantum leap is revolutionizing drug discovery and promises to transform healthcare from the ground up. The first companies to master this AI revolution will be the biggest winners in a billion-dollar market. We therefore take a look at three companies that are already using AI today: the Danish pharmaceutical giant Novo Nordisk, AI specialist NetraMark Holdings for clinical studies, and the German research service provider Evotec, and analyze their current situation.
Read
Commented by Carsten Mainitz on October 9th, 2025 | 07:35 CEST
BioNxt Solutions, Bayer, Evotec – Enormous upside! The interface of biotech and pharmaceuticals!
The global rise in lifestyle diseases such as diabetes, obesity, multiple sclerosis (MS), and MASH (metabolic fatty liver disease) is driving enormous growth in the healthcare sector. The market for cancer therapies is also expanding rapidly. Meanwhile, the M&A landscape is developing dynamically: large pharmaceutical companies need to act as patent protections expire, securing their pipeline through acquisitions and partnerships. Areas offering innovative drugs or novel delivery methods are especially attractive. This is where a promising second-tier stock comes into play.
Read
Commented by Nico Popp on October 9th, 2025 | 07:30 CEST
Digital business models for explosive growth: MiMedia, Peloton, Delivery Hero
Digital business models offer one key advantage: they can be scaled almost indefinitely. It is therefore no surprise that large parts of the global economy have now been digitized, or at least complemented by digital alternatives. Restaurants, for example, face competition from delivery platforms, while gyms compete with online fitness programs. Below, we highlight three digital business models - MiMedia, Peloton, and Delivery Hero - and explore where new opportunities for investors may be emerging today.
Read
Commented by André Will-Laudien on October 9th, 2025 | 07:25 CEST
E-mobility tax-free through 2035! Keep an eye on BYD, NEO Battery Materials, NIO and BASF
In the third quarter of 2025, the global market for electric mobility continued to develop dynamically: over 4.2 million new electric vehicles were registered, an increase of around 28% compared to the previous year. While China confidently maintained its leading position as the largest single market, Europe also grew strongly with double-digit growth rates. Driven by manufacturers such as BYD, Tesla, and Volkswagen, NIO is also slowly entering the scene. At the same time, more and more capital is flowing into innovative battery technologies to meet rising demand in the long term. NEO Battery Materials is emerging as a specialist in the innovative battery solutions business. This rapid development illustrates how closely technology, raw material markets, and the electric mobility boom are intertwined. We present some ideas for investors.
Read
Commented by Fabian Lorenz on October 9th, 2025 | 07:20 CEST
GOLD RUSH to USD 5,000? DEFENSE STOCKS set for a billion-dollar contract! Barrick Mining, Hensoldt and Kobo Resources!
While the US government shutdown drags on, the rush for tangible assets persists. The pace at which gold and silver prices are climbing is almost alarming. On the stock market, AI and defense remain key drivers. With surprising ease, the price of gold has broken through the USD 4,000 mark - could USD 5,000 be next? Barrick Mining is also continuing its rally, while those looking for undiscovered gems amid this hype should take a closer look at Kobo Resources. The junior explorer could soon become a potential takeover target. In the defense sector, the capital market is waiting for major orders. One such order could now come from the German government. Hensoldt stands among the likely beneficiaries.
Read
Commented by Nico Popp on October 9th, 2025 | 07:10 CEST
Dividends and growth? It is possible! With RE Royalties, Royalty Pharma or Evonik
The stock market is not just about price increases; dividends are also highly attractive. There are even professional investor groups that focus almost exclusively on continuous returns. Examples include pension funds and insurers. But why do companies in some sectors distribute more profits than others? We take a closer look at three exciting stocks that are also income generators and explain which business models offer the greatest potential from an investor's perspective.
Read
Commented by André Will-Laudien on October 9th, 2025 | 07:05 CEST
Hydrogen is finally here – 500% rally follows for Plug Power, Pure Hydrogen, nucera, and Nel ASA
For a long time, hydrogen stocks were very quiet. But now they have been kissed awake. Led by Plug Power, which posted a 300% turnaround in just two months, the upward momentum is now spreading across the entire sector. Nel ASA, the Norwegian pioneer, has had some weak quarters, making November a particularly exciting month. The Australian H2 powerhouse Pure Hydrogen has performed strongly since the beginning of the year. And the thyssenkrupp spin-off nucera is also making an impressive comeback. Are the protagonists already betting on the next wave of EU investment? Where are the opportunities for investors?
Read
Commented by Armin Schulz on October 9th, 2025 | 07:00 CEST
Almonty Industries' Raw material power brings Rheinmetall and Lockheed Martin into a new geopolitical era
Nations around the world are investing record sums in their defense capabilities. This defense boom is driving demand for critical raw materials to unprecedented heights. Suddenly, critical metals such as tungsten are at the center of global politics. They have become strategic commodities, with security of supply directly influencing military strength. This development is creating real momentum for companies covering the entire value chain, from mining to the defense industry to high-tech. Three stocks that perfectly embody this interplay between raw materials, production, and technology are Almonty Industries, Rheinmetall, and Lockheed Martin.
Read
Commented by André Will-Laudien on October 8th, 2025 | 07:30 CEST
BioNxt Solutions – A small biotech gem with huge potential
Modern medicine is undergoing a paradigm shift - and BioNxt Solutions could emerge as one of its key pioneers. The German-Canadian biotech company is developing innovative drug delivery platforms designed to make existing medications more effective, safer, and more patient-friendly. Whether for obesity, multiple sclerosis, or cancer, BioNxt is targeting several multi-billion-dollar markets with disruptive potential. Backed by patented technologies and an agile development strategy, BioNxt is laying the foundation for above-average growth and attractive licensing models. For investors, this could be a rare chance to get in early on what could be the next big thing in healthcare innovation.
Read
Commented by Carsten Mainitz on October 8th, 2025 | 07:25 CEST
Desert Gold, Barrick Mining, Nel ASA – Do not miss out: Favorites are changing in the bull market!
The stock markets are celebrating record highs. Many major indices are approaching—or have already surpassed—their all-time highs. Meanwhile, the price of gold is trading at around USD 4,000 per ounce, a historic level. Investors are closely watching the US Federal Reserve, as further interest rate cuts seem likely, providing additional tailwind for the markets. But as is often the case with upward trends, a change in favorites could be imminent. Here are some stocks that could soon accelerate into the fast lane.
Read